Schering Transactions To Avoid Tax On Repatriated Income Nixed By Court
Executive Summary
Schering-Plough lost its bid for a half billion tax refund when a court ruled that financial transactions set up to repatriate profits from foreign subsidiaries did not allow the company to delay paying taxes on the income. The decision has broad ramifications as it could impede corporations from forming similar arrangements
You may also be interested in...
Tight Credit Renews Interest In Lowering Tax On Repatriated Income
Billions of dollars held by pharmaceutical and other multinational companies in accounts outside the U.S. are being eyed as one remedy for tight credit markets
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials